A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1406-1411

  Frohlich Reiterer E E ^b   Ong, K K ^b,c   Regan, F ^b   Salzano, G ^b   Acerini, C L ^b   Dunger, D B ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC EPIDEMIOLOGY UNIT   (United Kingdom)

Author keywords

Children; Glargine; Hypoglycaemia; Three times daily; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING INSULIN;

ARTICLE; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSAGE SCHEDULE COMPARISON; DRUG DOSE TITRATION; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION SITE PAIN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORNING DOSAGE; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BLOOD GLUCOSE; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; PROSPECTIVE STUDIES;

EID: 36549056973     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02277.x     Document Type: Article

References (19)

1. Matyka KA, Crowne EC, Havel PJ, Macdonald IA, Matthews D, Dunger DB. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care 1999 22 : 1144 1150.
2. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003 26 : 662 667.
3. Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS et al. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 2004 27 : 2881 2886.
4. Bolli GB, Perriello G, Fanelli CG, De Feo P. Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care 1993 16 : 71 89.
5. Mohn A, Strang S, Wernicke-Panten K, Lang AM, Edge JA, Dunger DB. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care 2000 23 : 557 559.
6. Campbell RK, White JR, Levien T, Baker D. Insulin glargine. Clin Ther 2001 23 : 1938 57 discussion 1923.
7. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000 49 : 2142 2148.
8. Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K Paediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002 15 : 369 376.
9. 1c in children and adolescents with poorly controlled type 1 diabetes. Pediatr Diabetes 2003 4 : 64 69.
10. Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003 143 : 737 740.
11. Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Diabetes Care 2003 26 : 799 804.
12. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. US Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000 23 : 639 643.
13. Tan CY, Wilson DM, Buckingham B. Initiation of insulin glargine in children and adolescents with type 1 diabetes. Pediatr Diabetes 2004 5 : 80 86.
14. Khadilkar VV, Khadilkar AV. Concomitant use of insulin glargine and NPH in Type I diabetes. Indian Pediatr 2005 42 : 796 800.
15. Holl RW, Swift PGF, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore Study Group. Eur J Pediatr 2003 162 : 22 29.
16. Matyka KA, Wigg L, Pramming S, Stores G, Dunger DB. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Arch Dis Child 1999 81 : 138 142.
17. Marrero DG, Guare JC, Vandagriff JL, Fineberg NS. Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 1997 23 : 281 286.
18. Mohn A, Matyka KA, Harris DA, Ross KM, Edge JA, Dunger DB. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care 1999 22 : 27 32.
19. Ford-Adams ME, Murphy NP, Moore EJ, Edge JA, Ong K, Watts AP et al. Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus. Diabet Med 2003 20 : 656 660.